George C. Clark has not been actively trading shares of Biohaven Pharmaceutical within the last three months. Most recently, George C. Clark sold 4,200 shares of the business's stock in a transaction on Tuesday, May 10th. The shares were sold at an average price of $141.50, for a transaction totalling $594,300.00. Following the completion of the sale, the chief accounting officer now directly owns 4,065 shares of the company's stock, valued at $575,197.50. Learn More on George C. Clark's trading history.